U.S. Semiconductors Stock News

If you are wondering whether Sensient Technologies stock still offers value at current levels, this article focuses squarely on what the numbers say about its price. Over recent periods, the stock has recorded returns of 6.3% over 7 days, 3.8% over 30 days, 27.1% year to date, 23.3% over 1 year, 80.8% over 3 years, and 52.4% over 5 years. This naturally raises questions about how its current valuation stacks up. Recent coverage around Sensient Technologies has focused on its role in the...

Bitmine Immersion Technologies (NYSE:BMNR) is approaching inclusion in the Russell 1000 index, which would trigger buying by index-tracking funds once finalized. The company has co founded Ethlabs, a new nonprofit research lab focused on Ethereum, with the goal of supporting institutional use of the network. Bitmine Immersion Technologies operates in the crypto infrastructure space, where institutional interest in digital assets and blockchain tooling continues to evolve. Potential...

With the US Federal Reserve under Kevin Warsh signaling a more hawkish stance and bond yields reacting, short term US Treasury and government bond ETFs are back in focus for investors weighing risk and income. As markets adjust to the prospect of rate hikes and a smaller, less interventionist central bank, some stocks exposed to this news may appear better positioned than others. This article walks through three positively exposed stocks from the Short-Term US Treasury and Government Bond...

Aeluma stock: recent moves in context Aeluma (ALMU) shares have seen mixed recent performance, with the stock down 6.4% on the day and 7.5% over the past week, while still up over the past 3 months and year to date. For investors tracking shorter term swings alongside longer term performance, these moves raise questions about how current pricing lines up with Aeluma’s revenue of US$5.196 million and its reported net loss of US$6.004 million. See our latest analysis for Aeluma. At a share...

On 23 June 2026, TD Cowen analyst Kyle Boucher reiterated a positive view on Bio-Techne, describing it as a premier small to mid-cap option despite ongoing life sciences market softness and recent insider selling. His comments, alongside a broader consensus that still sees moderate upside for the company despite funding and demand headwinds, suggest investors are reassessing how Bio-Techne is valued within a challenged sector. Next, we'll examine how this renewed analyst confidence, despite...

MoonLake Immunotherapeutics (MLTX) has become a focus for many investors after strong one-year Phase 3 VELA data for sonelokimab in hidradenitis suppurativa and a planned Biologics License Application filing by the end of September. See our latest analysis for MoonLake Immunotherapeutics. That clinical update has come alongside a sharp move in MoonLake Immunotherapeutics’ share price, with a 7-day share price return of 11.80% and a 30-day share price return of 16.66%. However, the 1-year...

Cencora (NYSE:COR) has launched a multi site pilot of its enhanced Nucleus inventory management solution for specialty physician practices. The company also announced an executive transition in the Chief Human Resources Officer role, bringing in a CHRO from another large corporation. Cencora is drawing attention with these linked operational and leadership moves, as investors weigh what they might mean for the business. The stock recently closed at $281.1, with a value score of 6 and long...

American Tower (NYSE:AMT) is expanding its data center operations as demand tied to AI workloads and multicloud deployments increases. The company is emphasizing its role in digital infrastructure that supports cloud computing alongside its traditional tower leasing business. This shift highlights how AI and cloud trends are influencing American Tower's mix of assets and services. For investors used to thinking of American Tower mainly as a tower landlord, the growing focus on data centers...

Quantum Computing Inc. (NasdaqCM:QUBT) has completed its acquisition of NHanced Semiconductors. The deal brings NHanced in as a wholly owned subsidiary of Quantum Computing Inc. The company has launched Fab 2 to support commercial quantum and photonic hardware production. For Quantum Computing Inc., this acquisition is a significant move into chip manufacturing and advanced packaging, which sit at the heart of quantum and photonic hardware. As more computing workloads push into areas like...

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings projected to grow by 19% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies with strong innovation and scalability potential that can thrive despite short-term market fluctuations.

From what we can see, insiders were net buyers in System1, Inc.'s ( NYSE:SST ) during the past 12 months. That is...

Over the last 7 days, the U.S. market has dropped 2.3%, but it is up 21% over the past year with earnings forecasted to grow by 19% annually. In light of these conditions, identifying stocks with strong fundamentals and growth potential can be key to navigating market fluctuations. Penny stocks, though an older term, still represent a viable investment area; they often involve smaller or newer companies that offer unique growth opportunities at lower price points.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains robust with a 21% increase over the past year and an earnings forecast predicting a 19% annual growth. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer unique opportunities for investors seeking to capitalize on these positive trends.

Over the last 7 days, the United States market has dropped 2.3%, though it remains up by 21% over the past year, with earnings forecasted to grow by 19% annually. In this dynamic environment, identifying strong dividend stocks can be an effective strategy for investors seeking stability and income amidst fluctuating market conditions.

BTCS Inc.'s (NASDAQ:BTCS) value has fallen 10% in the last week, but insiders who sold US$1.3m worth of stock over the...

In June 2026, Getty Images announced a multi-year display agreement with OpenAI that will integrate its licensed visual content libraries into ChatGPT’s search and discovery features, enriching on-platform visual responses with authenticated imagery. This move places Getty Images’ rights-cleared library at the heart of one of the world’s most widely used AI interfaces, highlighting how licensed content can underpin more trustworthy visual AI experiences. We’ll now examine how this OpenAI...

Flutter Entertainment plans to delist from the London Stock Exchange and move to a sole NYSE listing under ticker NYSE:FLUT. The company outlined the intention following a review of trading activity and regulatory considerations. The decision marks a structural shift in how Flutter Entertainment engages with public markets and its shareholder base. Flutter Entertainment is set to concentrate its listing in the US market, with NYSE:FLUT becoming its primary trading venue. The move comes at a...

Primoris Services (NYSE:PRIM) sharply cut its 2026 profit and renewables revenue guidance. The company reported persistent cost overruns and project delays in its Renewables segment. Primoris Services announced the sudden departure of its Chief Operating Officer. Multiple law firms have launched investigations following a steep share price drop. Primoris Services (NYSE:PRIM) is under pressure after a sharp reset to its 2026 earnings outlook and renewables revenue guidance, combined with the...

uniQure (NasdaqGS:QURE) reported positive initial data from its Phase I/IIa trial of AMT-260 for refractory mesial temporal lobe epilepsy. Several patients in the initial low dose cohort experienced meaningful seizure reduction, with an encouraging safety profile. This is the first clinical efficacy and safety readout for AMT-260, expanding uniQure's pipeline beyond Huntington's disease. uniQure, trading at $49.04, is drawing fresh attention as AMT-260 moves from concept to early clinical...

Talphera, Inc. ( NASDAQ:TLPH ) insiders who bought shares over the past year were rewarded handsomely last week. The...

Insiders who acquired US$611.2k worth of Sintx Technologies, Inc.'s ( NASDAQ:SINT ) stock at an average price of...

Last week, DiaMedica Therapeutics Inc. ( NASDAQ:DMAC ) insiders, who had purchased shares in the previous 12 months...

Zeta Global Holdings (NYSE:ZETA) has entered into a partnership with Palantir Technologies to build a unified enterprise AI infrastructure layer for marketing. The collaboration centers on rearchitecting Zeta’s Data Cloud on Palantir’s Foundry platform and integrating Zeta’s Athena AI to support real-time marketing decisions. Both companies point to the potential for this integration to support new revenue streams tied to large enterprise marketing use cases. Zeta Global Holdings comes into...

Iovance Biotherapeutics (NasdaqGM: IOVA) received conditional approval in Australia for Amtagvi, its T-cell therapy for advanced melanoma. The Therapeutic Goods Administration decision marks the third marketing authorization for Amtagvi after the US and Canada. Amtagvi becomes the first approved solid tumor T-cell therapy in the Australian market and is supported by an Australian treatment center. Iovance Biotherapeutics focuses on cell therapies that use a patient's own T cells to target...